Literature DB >> 19322730

Evaluation of heterogeneity in pharmacotherapy trials for drug dependence: a Bayesian approach.

C E Green1, F G Moeller, J M Schmitz, J F Lucke, S D Lane, A C Swann, R E Lasky, J P Carbonari.   

Abstract

AIMS: Difficulty identifying effective pharmacotherapies for cocaine dependence has led to suggestions that subgroup differences may account for some of the heterogeneity in treatment response. Well-attested methodological difficulties associated with these analyses recommend the use of Bayesian statistical reasoning for evaluation of salient interaction effects.
METHODS: A secondary data analysis of a previously published, double-blind, randomized controlled trial examines the interaction of decision-making, as measured by the Iowa Gambling Task, and citalopram in increasing longest sustained abstinence from cocaine use.
RESULTS: Bayesian analysis indicated that there was a 99% chance that improved decision-making enhances response to citalopram. Given the strong positive nature of this finding, a formal, quantitative Bayesian approach to evaluate the result from the perspective of a skeptic was applied.
CONCLUSIONS: Bayesian statistical reasoning provides a formal means of weighing evidence for the presence of an interaction in scenarios where conventional, Frequentist analyses may be less informative. [Supplementary materials are available for this article. Go to the publisher's online edition of The American Journal of Drug and Alcohol Abuse for the following free supplemental resource: Appendix 1].

Entities:  

Mesh:

Substances:

Year:  2009        PMID: 19322730      PMCID: PMC4429522          DOI: 10.1080/00952990802647503

Source DB:  PubMed          Journal:  Am J Drug Alcohol Abuse        ISSN: 0095-2990            Impact factor:   3.829


  39 in total

Review 1.  Neurochemical individuality: genetic diversity among human dopamine and serotonin receptors and transporters.

Authors:  A Cravchik; D Goldman
Journal:  Arch Gen Psychiatry       Date:  2000-12

2.  Subgroup analyses in randomized trials: risks of subgroup-specific analyses; power and sample size for the interaction test.

Authors:  Sara T Brookes; Elise Whitely; Matthias Egger; George Davey Smith; Paul A Mulheran; Tim J Peters
Journal:  J Clin Epidemiol       Date:  2004-03       Impact factor: 6.437

3.  Treating individuals 2. Subgroup analysis in randomised controlled trials: importance, indications, and interpretation.

Authors:  Peter M Rothwell
Journal:  Lancet       Date:  2005 Jan 8-14       Impact factor: 79.321

Review 4.  Primer: the fallacy of subgroup analysis.

Authors:  Francis Guillemin
Journal:  Nat Clin Pract Rheumatol       Date:  2007-07

5.  Bayesian design and analysis of two x two factorial clinical trials.

Authors:  R Simon; L S Freedman
Journal:  Biometrics       Date:  1997-06       Impact factor: 2.571

6.  Prime time for Bayes.

Authors:  J B Kadane
Journal:  Control Clin Trials       Date:  1995-10

Review 7.  Pharmacogenetics and human molecular genetics of opiate and cocaine addictions and their treatments.

Authors:  Mary Jeanne Kreek; Gavin Bart; Charles Lilly; K Steven LaForge; David A Nielsen
Journal:  Pharmacol Rev       Date:  2005-03       Impact factor: 25.468

8.  Decision-making and addiction (part I): impaired activation of somatic states in substance dependent individuals when pondering decisions with negative future consequences.

Authors:  Antoine Bechara; Hanna Damasio
Journal:  Neuropsychologia       Date:  2002       Impact factor: 3.139

9.  Polymorphism in the serotonin transporter gene and moderators of prolactin response to meta-chlorophenylpiperazine in African-American cocaine abusers and controls.

Authors:  Paolo Mannelli; Ashwin A Patkar; Kathleen Peindl; Haresh Tharwani; Raman Gopalakrishnan; Kevin P Hill; Wade H Berrettini
Journal:  Psychiatry Res       Date:  2006-09-25       Impact factor: 3.222

10.  The miracle of DICE therapy for acute stroke: fact or fictional product of subgroup analysis?

Authors:  C E Counsell; M J Clarke; J Slattery; P A Sandercock
Journal:  BMJ       Date:  1994 Dec 24-31
View more
  14 in total

1.  Relationship between impulsivity and decision making in cocaine dependence.

Authors:  Kimberly L Kjome; Scott D Lane; Joy M Schmitz; Charles Green; Liangsuo Ma; Irshad Prasla; Alan C Swann; F Gerard Moeller
Journal:  Psychiatry Res       Date:  2010-05-15       Impact factor: 3.222

2.  Demographic and psychological factors associated with lifetime cocaine use: An exploratory factor analysis of baseline questionnaires.

Authors:  Nadeeka R Dias; Scott D Lane; Nuvan Rathnayaka; Joy M Schmitz; Charles E Green
Journal:  Addict Disord Their Treat       Date:  2015-06

3.  PPAR-gamma agonist pioglitazone modifies craving intensity and brain white matter integrity in patients with primary cocaine use disorder: a double-blind randomized controlled pilot trial.

Authors:  Joy M Schmitz; Charles E Green; Khader M Hasan; Jessica Vincent; Robert Suchting; Michael F Weaver; F Gerard Moeller; Ponnada A Narayana; Kathryn A Cunningham; Kelly T Dineley; Scott D Lane
Journal:  Addiction       Date:  2017-07-03       Impact factor: 6.526

4.  A stage I pilot study of acceptance and commitment therapy for methadone detoxification.

Authors:  Angela L Stotts; Charles Green; Akihiko Masuda; John Grabowski; Kelly Wilson; Thomas F Northrup; F Gerard Moeller; Joy M Schmitz
Journal:  Drug Alcohol Depend       Date:  2012-03-15       Impact factor: 4.492

Review 5.  Recent research on impulsivity in individuals with drug use and mental health disorders: implications for alcoholism.

Authors:  Robert D Rogers; Frederick G Moeller; Alan C Swann; Luke Clark
Journal:  Alcohol Clin Exp Res       Date:  2010-06-07       Impact factor: 3.455

6.  Benefits of varenicline vs. bupropion for smoking cessation: a Bayesian analysis of the interaction of reward sensitivity and treatment.

Authors:  Paul M Cinciripini; Charles E Green; Jason D Robinson; Maher Karam-Hage; Jeffrey M Engelmann; Jennifer A Minnix; David W Wetter; Francesco Versace
Journal:  Psychopharmacology (Berl)       Date:  2017-03-08       Impact factor: 4.530

7.  Anhedonia Is Associated with Poorer Outcomes in Contingency Management for Cocaine Use Disorder.

Authors:  Margaret C Wardle; Jessica N Vincent; Robert Suchting; Charles E Green; Scott D Lane; Joy M Schmitz
Journal:  J Subst Abuse Treat       Date:  2016-09-09

Review 8.  Serotonin at the nexus of impulsivity and cue reactivity in cocaine addiction.

Authors:  Kathryn A Cunningham; Noelle C Anastasio
Journal:  Neuropharmacology       Date:  2013-07-11       Impact factor: 5.250

9.  Working memory fMRI activation in cocaine-dependent subjects: association with treatment response.

Authors:  F Gerard Moeller; Joel L Steinberg; Joy M Schmitz; Liangsuo Ma; Shijing Liu; Kimberly L Kjome; Nuvan Rathnayaka; Larry A Kramer; Ponnada A Narayana
Journal:  Psychiatry Res       Date:  2010-02-12       Impact factor: 3.222

10.  Functional status of the serotonin 5-HT2C receptor (5-HT2CR) drives interlocked phenotypes that precipitate relapse-like behaviors in cocaine dependence.

Authors:  Noelle C Anastasio; Sonja J Stutz; Robert G Fox; Robert M Sears; Ronald B Emeson; Ralph J DiLeone; Richard T O'Neil; Latham H Fink; Dingge Li; Thomas A Green; F Gerard Moeller; Kathryn A Cunningham
Journal:  Neuropsychopharmacology       Date:  2013-08-13       Impact factor: 7.853

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.